Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J D Jackson

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
Scientific Reports|May 11, 2018
Human Cortex Spheroid with a Functional Blood Brain Barrier for High-Throughput Neurotoxicity Screening and Disease ModelingGoodwell Nzou, R T Wicks, E E Wicks, et al.
Blood|January 15, 1994
High-dose therapy and peripheral blood progenitor cell transplantation: effects of recombinant human granulocyte-macrophage colony-stimulating factor on the autograftM R Bishop, J R Anderson, J D Jackson, et al.
Gene Therapy|August 15, 2014
Assessment of oncolytic HSV efficacy following increased entry-receptor expression in malignant peripheral nerve sheath tumor cell linesJ D Jackson, A M McMorris, J C Roth, et al.
The New England Journal of Medicine|March 21, 1985
Clinical computing in a teaching hospitalH L Bleich, R F Beckley, G L Horowitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1996
Phase I trial of recombinant fusion protein PIXY321 for mobilization of peripheral-blood cellsM R Bishop, J D Jackson, B O'Kane-Murphy, et al.
Experimental Hematology|July 1, 1995
Erythropoietin for mobilization of circulating progenitor cells in patients with previously treated relapsed malignanciesA Kessinger, M R Bishop, J D Jackson, et al.
Leukemia & Lymphoma|December 1, 1995
Effects of BCR-ABL antisense oligonucleotides (AS-ODN) on human chronic myeloid leukemic cells: AS-ODN as effective purging agentsA G Wu, S S Joshi, W C Chan, et al.
Mechanisms of Ageing and Development|November 2, 2010
Human blood and marrow side population stem cell and Stro-1 positive bone marrow stromal cell numbers decline with age, with an increase in quality of surviving stem cells: correlation with cytokinesS K Brusnahan, T R McGuire, J D Jackson, et al.
Leukemia & Lymphoma|November 9, 2001
Oligonucleotide enhanced cytotoxicity of Idarubicin for lymphoma cellsJ G Sharp, M R Bishop, B Copple, et al.
Journal of Hematotherapy|November 22, 1997
Ex vivo treatment of bone marrow with phosphorothioate oligonucleotide OL(1)p53 for autologous transplantation in acute myelogenous leukemia and myelodysplastic syndromeM R Bishop, J D Jackson, S R Tarantolo, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
Scientific Reports|May 11, 2018
Human Cortex Spheroid with a Functional Blood Brain Barrier for High-Throughput Neurotoxicity Screening and Disease ModelingGoodwell Nzou, R T Wicks, E E Wicks, et al.
Blood|January 15, 1994
High-dose therapy and peripheral blood progenitor cell transplantation: effects of recombinant human granulocyte-macrophage colony-stimulating factor on the autograftM R Bishop, J R Anderson, J D Jackson, et al.
Gene Therapy|August 15, 2014
Assessment of oncolytic HSV efficacy following increased entry-receptor expression in malignant peripheral nerve sheath tumor cell linesJ D Jackson, A M McMorris, J C Roth, et al.
The New England Journal of Medicine|March 21, 1985
Clinical computing in a teaching hospitalH L Bleich, R F Beckley, G L Horowitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1996
Phase I trial of recombinant fusion protein PIXY321 for mobilization of peripheral-blood cellsM R Bishop, J D Jackson, B O'Kane-Murphy, et al.
Experimental Hematology|July 1, 1995
Erythropoietin for mobilization of circulating progenitor cells in patients with previously treated relapsed malignanciesA Kessinger, M R Bishop, J D Jackson, et al.
Leukemia & Lymphoma|December 1, 1995
Effects of BCR-ABL antisense oligonucleotides (AS-ODN) on human chronic myeloid leukemic cells: AS-ODN as effective purging agentsA G Wu, S S Joshi, W C Chan, et al.
Mechanisms of Ageing and Development|November 2, 2010
Human blood and marrow side population stem cell and Stro-1 positive bone marrow stromal cell numbers decline with age, with an increase in quality of surviving stem cells: correlation with cytokinesS K Brusnahan, T R McGuire, J D Jackson, et al.
Leukemia & Lymphoma|November 9, 2001
Oligonucleotide enhanced cytotoxicity of Idarubicin for lymphoma cellsJ G Sharp, M R Bishop, B Copple, et al.
Journal of Hematotherapy|November 22, 1997
Ex vivo treatment of bone marrow with phosphorothioate oligonucleotide OL(1)p53 for autologous transplantation in acute myelogenous leukemia and myelodysplastic syndromeM R Bishop, J D Jackson, S R Tarantolo, et al.
Pageof 10